Leaflet LUIVAC 3mg tablets

Product code:
W64346001
Quantity:
28
Indicated for:
prevention of recurrent respiratory infections
Route of administration:
oral
Substance:
biological products (bacterial lysates) (immunomodulator)
ATC
L03AXN1 — Antineoplastic and immunomodulating agents | Immunostimulants | Immunostimulants | Other immunostimulants

Precautions:

Avoid live vaccines

Avoid live vaccines during treatment if contraindicated.

Immunosuppression / infection risk

This medicine may increase the risk of infections.

Breastfeeding warning

Use during breastfeeding only on medical advice.

Pregnancy warning

Use during pregnancy only on medical advice.

Biological products based on bacterial lysates are used to stimulate the immune system in the prevention and treatment of recurrent respiratory infections. They contain fragments of inactivated bacteria that stimulate the body's immune response.

The product is administered orally, usually in the form of capsules or tablets, as directed by the doctor. It is important to follow the treatment regimen to achieve maximum benefits.

Side effects may include nausea, abdominal discomfort, or, in rare cases, allergic reactions.

Patients should inform their doctor about any other medications being used or pre-existing conditions to ensure the safe use of biological products based on bacterial lysates.

General data about LUIVAC 3mg

Substance:
biological products (bacterial lysates)
Date of latest medicines list:
01-10-2024
Product code:
W64346001
Concentration:
3mg
Pharmaceutical form:
tablets
Quantity:
28
Product type:
Original
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

Manufacturer:
DAIICHI SANKYO EUROPE GMBH - GERMANIA
Holder:
ALVOGEN MALTA OPERATIONS (ROW) LTD. - MALTA
Number:
4595/2012/01
Shelf life:
2 years